Gilead Sciences at AAPS 2026 PharmSci 360

Oct 25–28, 2026 New Orleans, LA ~4k attendees Website

Gilead Sciences brings 4 presentations to AAPS 2026 PharmSci 360 in New Orleans. Its program spans model-informed dose adjustment, isotope labeling to find hidden drug metabolism risks and crystallization of a poorly soluble salt. Its sessions also test how electron beam and gamma sterilization affect rubber stoppers.

OrganizationAAPS 2026 PharmSci 360 Attendance
Gilead Sciences
Foster City, CA
Large pharma
Biopharmaceutical company with medicines for HIV, viral hepatitis, cancer and inflammatory diseases.
Poster
Tue Oct 27
10:30am–11:30am
Impact of E-Beam and Gamma Irradiation Terminal Sterilization on Functional Performance of Elastomeric Stoppers
Solution Center · Poster T1030-02-07
Formulation and Delivery - Chemical
Session
Wed Oct 28
9:00am–11:00am
Symposium: Adaptive Dosage Modifications - MIDD Opportunities & Challenges
Preclinical, Clinical, and Translational Sciences
Talk
Wed Oct 28
9:30am–10:00am
Part of Symposium: Innovations in Clinical Sampling and BA Lab AI/Automation
Seeing the Invisible: Isotope‑Labeling Strategies for Detecting Hidden DMPK Liabilities
211-213
Bioanalytics
Poster
Wed Oct 28
10:30am–11:30am
Crystallization Process Development to Increase Primary Particle Growth for a Low Soluble Mono-Citrate Salt, Edecesertib
Solution Center · Poster W1030-07-41
Manufacturing and Analytical Characterization - Chemical

Explore the full AAPS 2026 PharmSci 360 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in New Orleans. Leave your work email and we’ll be in touch.

Privacy

Download the full AAPS 2026 PharmSci 360 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from Gilead Sciences

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by the American Association of Pharmaceutical Scientists (AAPS). Submit a correction